Single-dose intravenous iron infusion versus red blood cell transfusion for the treatment of severe postpartum anaemia: a randomized controlled pilot study

Vox Sanguinis

Volumn 112, Issue 2, 2017, Pages 122-131

  Holm, C ^a,b   Thomsen, L L ^b   Norgaard, A ^a   Langhoff Roos, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Pharmacosmos AS   (Denmark)

Author keywords

clinical trial; haemoglobin measurement; medicine; patient blood management; transfusion

Indexed keywords

HEMOGLOBIN; IRON; IRON ISOMALTOSIDE; UNCLASSIFIED DRUG; DISACCHARIDE; FERRIC ION; IRON ISOMALTOSIDE 1000;

ADULT; ANEMIA; ARTICLE; BACKACHE; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON STORAGE; LOW BACK PAIN; NECK PAIN; PATIENT-REPORTED OUTCOME; PILOT STUDY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTOSIS; SEVERE POSTPARTUM ANEMIA; SINGLE DRUG DOSE; THORAX PAIN; ADVERSE EFFECTS; CLINICAL TRIAL; DEPRESSION; DRUG EFFECTS; FEASIBILITY STUDY; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; PREGNANCY; PUERPERIUM; SEVERITY OF ILLNESS INDEX;

ADULT; ANEMIA; DEPRESSION; DISACCHARIDES; ERYTHROCYTE TRANSFUSION; FATIGUE; FEASIBILITY STUDIES; FEMALE; FERRIC COMPOUNDS; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; PILOT PROJECTS; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; RETICULOCYTOSIS; SEVERITY OF ILLNESS INDEX;

EID: 85007426093     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12475     Document Type: Article

References (24)

1. Holm C, Langhoff-Roos J, Petersen KB, et al.: Severe postpartum haemorrhage and mode of delivery: a retrospective cohort study. Br J Obstet Gynaecol 2012; 119:596–604
2. Lee KA, Zaffke ME: Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs 1999; 28:183–191
3. Corwin EJ, Murray-Kolb LE, Beard JL: Low hemoglobin level is a risk factor for postpartum depression. J Nutr 2003; 133:4139–4142
4. Jansen AJ, van Rhenen DJ, Steegers EA, et al.: Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005; 60:663–671
5. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4. Art. No.: CD002042. doi:10.1002/14651858.CD002042.pub3
6. Lee T-H, Paglieroni T, Utter GH, et al.: High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005; 45:1280–1290
7. Salpeter SR, Buckley JS, Chatterjee S: Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014; 127:124–131.e3
8. Norgaard A, Gybel-Brask M, Rieneck K, et al.: Managing the bleeding emergency in a patient with red cell antibodies. ISBT sci ser 2016; 11(Suppl. 1):44–53
9. Pavord S, Myers B, Robinson S, et al.: UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2012; 156:588–600
10. Prick BW, Jansen A, Steegers E, et al.: Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. Br J Obstet Gynaecol 2014; 121:1005–1014
11. Broche DE, Gay C, Armand-Branger S, et al.: Anémies sévères du post-partum immédiat. Pratique clinique et intérêt du fer par voie intraveineuse. Gynecol Obstet Fertil 2004; 32:613–619
12. Smets EM, Garssen B, Bonke B, et al.: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39:315–325
13. Cox JL, Holden JM, Sagovsky R: Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150:782–786
14. Jansen AJ, Essink-Bot M-L, Duvekot JJ, et al.: Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res 2007; 63:275–281
15. Wood KL, On Behalf of the Meddra Working Party. The medical dictionary for drug regulatory affairs (MEDDRA) project. Pharmacoepidemiol Drug Saf 1994; 3:7–13
16. Sundhedsstyrelsen. National klinisk retningslinje om indikation for transfusion med blodkomponenter [Internet]. Copenhagen: Sundhedsstyrelsen; 2014. Available from Sundhedsstyrelsen: https://sundhedsstyrelsen.dk/da/udgivelser/2014/~/media/EEA1EA90C15E4A97B9E786D2850B3664.ashx [Last accessed 20 May 2016]
17. Silverman JA, Barrett J, Callum JL: The appropriateness of red blood cell transfusions in the peripartum patient. Obstet Gynecol 2004; 104:1000–1004
18. So-Osman C, Cicilia J, Brand A, et al.: Triggers and appropriateness of red blood cell transfusions in the postpartum patient–a retrospective audit. Vox Sang 2010; 98:65–69
19. Carson JL, Grossman BJ, Kleinman S, et al.: Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 2012; 157:49–58
20. Perry ES, Moore RH, Berger TA, et al.: In vitro and in vivo persistence of reticulocytes from donor red cells. Transfusion 1996; 36:318–321
21. Larsen R, Berkowicz A, Lousen T, et al.: Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry. Transfusion 2008; 48:1707–1712
22. Auerbach M, Ballard H, Glaspy J: Clinical update: intravenous iron for anaemia. Lancet 2007; 369:1502–1504
23. Fishbane S, Ungureanu VD, Maesaka JK, et al.: The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996; 28:529–534
24. Rampton D, Folkersen J, Fishbane S, et al.: Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99:1671–1676